SIOUX FALLS, S.D., Nov. 13, 2017 -- Raven Industries, Inc. (NASDAQ:RAVN) announced today that Mark Griffin will retire from the company’s Board of Directors effective December 4, 2017.
“Raven has benefited greatly from Mark’s leadership and guidance during his tenure on the board of directors,” said Marc LeBaron, Raven’s Chairman of the Board. “His business acumen, along with his deep understanding of the Raven culture, has been invaluable.”
Having served on the board since 1987, Mr. Griffin most recently chaired the Personnel & Compensation Committee.
“I’m honored to have served on the Raven board for 30 years,” said Griffin. “Watching the company grow and establish itself as an innovative, service-driven technology company has truly been a fulfilling experience. While I’m stepping down to concentrate on my business, Lewis Drug, and to serve on several drugstore industry boards, I believe Raven is well-positioned for success in the years to come.”
Raven Industries President and CEO Dan Rykhus stated, “We thank Mark for his wise counsel and many contributions throughout his long tenure. He has represented our shareholders well, and we will miss his leadership and perspective.”
The company’s board plans to select a suitable replacement to fill the vacancy in the coming weeks.
About Raven Industries, Inc.
Raven Industries (NASDAQ:RAVN) is dedicated to providing innovative, high-value products and solutions that solve great challenges throughout the world. Raven is a leader in precision agriculture, high-performance specialty films, and lighter-than-air technologies. Since 1956, Raven has designed, produced, and delivered exceptional solutions, earning the company a reputation for innovation, product quality, high performance, and unmatched service. For more information, visit http://ravenind.com.
Contact Information
Margaret Carmody, Director of Communications
Raven Industries, Inc.
+1 (605) 336-2750


Russia Signals Further Restrictions on Telegram Amid Ongoing Regulatory Disputes
Samsung Electronics Shares Jump on HBM4 Mass Production Report
Samsung Electronics Sees Sustained AI-Driven Demand for Memory Chips Into Next Year
FDA Rejects Review of Moderna’s Flu Vaccine Application, Shares Slide
Standard Chartered Names Peter Burrill as Interim Group CFO Following Diego De Giorgi’s Exit
Salesforce Workforce Reduction Affects Fewer Than 1,000 Roles Amid Ongoing Restructuring
Treasury Wine Estates Shares Surge After U.S. Dispute Settlement and Earnings Upgrade
ByteDance Advances AI Chip Development With Samsung Manufacturing Talks
Ancora Holdings Builds $200M Stake in Warner Bros Discovery, Targets Netflix Asset Sale Plan
SMIC Shares Slide Despite Strong AI-Driven Earnings as Margin Pressure Looms
CBA Shares Surge After Record Half-Year Profit as Rate Outlook Improves
Alphabet Plans Rare 100-Year Sterling Bond to Fund AI Expansion
Ralph Lauren Unveils Elegant Fall 2026 Women’s Collection Ahead of New York Fashion Week
xAI Co-Founder Jimmy Ba Departs as Elon Musk’s AI Startup Faces Turbulence
Cloudflare Forecasts Strong Revenue Growth as AI Fuels Cloud Services Demand
Petrobras Posts Record Oil Exports as Production Surge Fuels Global Expansion
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine 



